|
"chuang wl"的相关文件
显示项目 1-50 / 84 (共2页)
1 2 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2025-02-19 |
Air pollution associated with mortality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
|
Jang, TY;Zeng, YT;Liang, PC;Wu, CD;Wei, YJ;Tsai, PC;Hsieh, MY;Lin, YH;Hsieh, MH;Wang, CW;Yang, JF;Yeh, ML;Huang, CF;Chuang, WL;Huang, JF;Cheng, YY;Dai, CY;Chen, PC;Yu, ML |
| 國家衛生研究院 |
2025-02-13 |
Air pollution causes abnormal alanine aminotransferase levels in patients with chronic hepatitis B
|
Jang, TY;Zeng, YT;Liang, PC;Wu, CD;Wei, YJ;Tsai, PC;Hsu, PY;Tsai, YS;Hsieh, MY;Lin, YH;Hsieh, MH;Wang, CW;Yang, JF;Yeh, ML;Huang, CF;Chuang, WL;Huang, JF;Batsaikhan, B;Dai, CY;Chen, PC;Yu, ML |
| 國家衛生研究院 |
2024-11-26 |
Role of air pollution in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
|
Jang, TY;Zeng, YT;Liang, PC;Wu, CD;Wei, YJ;Tsai, PC;Hsu, PY;Hsieh, MY;Lin, YH;Hsieh, MH;Wang, CW;Yang, JF;Yeh, ML;Huang, CF;Chuang, WL;Huang, JF;Cheng, YY;Dai, CY;Chen, PC;Yu, ML |
| 國家衛生研究院 |
2024-11-07 |
Epidemiology and analysis of SARS-CoV-2 Omicron subvariants BA.1 and 2 in Taiwan[Erratum:Scientific Reports. 2023 Oct 03;13:Article number 16583.]
|
Liu, LT;Chiou, SS;Chen, PC;Chen, CH;Lin, PC;Tsai, CY;Chuang, WL;Hwang, SJ;Chong, IW;Tsai, JJ |
| 國家衛生研究院 |
2024-11 |
The epidemiology and phylogenetic trends of Omicron subvariants from BA.5 to XBB.1 in Taiwan
|
Tsai, JJ;Chiou, SS;Chen, PC;Chen, CH;Lin, PC;Tsai, CY;Chuang, WL;Hwang, SJ;Chong, IW;Liu, LT |
| 國家衛生研究院 |
2024-04-16 |
The efficacy of multi-disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patients
|
Yeh, ML;Dai, CY;Huang, CF;Huang, SF;Tsai, PC;Hsu, PY;Huang, C;Wei, YJ;Liang, PC;Bair, MJ;Lee, MH;Lin, ZY;Huang, JF;Yu, ML;Chuang, WL |
| 國家衛生研究院 |
2023-11-10 |
Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease
|
Jang, TY;Ho, CC;Liang, PC;Wu, CD;Wei, YJ;Tsai, PC;Hsu, PY;Hsieh, MY;Lin, YH;Hsieh, MH;Wang, CW;Yang, JF;Yeh, ML;Huang, CF;Chuang, WL;Huang, JF;Cheng, YY;Dai, CY;Chen, PC;Yu, ML |
| 國家衛生研究院 |
2023-10-27 |
Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs
|
Jang, TY;Liang, PC;Jun, DW;Jung, JH;Toyoda, H;Wang, CW;Yuen, MF;Cheung, KS;Yasuda, S;Kim, SE;Yoon, EL;An, J;Enomoto, M;Kozuka, R;Chuma, M;Nozaki, A;Ishikawa, T;Watanabe, T;Atsukawa, M;Arai, T;Hayama, K;Ishigami, M;Cho, YK;Ogawa, E;Kim, HS;Shim, JJ;Uojima, H;Jeong, SW;Ahn, SB;Takaguchi, K;Senoh, T;Buti, M;Vargas-Accarino, E;Abe, H;Takahashi, H;Inoue, K;Huang, JF;Chuang, WL;Yeh, ML;Dai, CY;Huang, CF;Nguyen, MH;Yu, ML |
| 國家衛生研究院 |
2023-10-03 |
Epidemiology and analysis of SARS-CoV-2 Omicron subvariants BA.1 and 2 in Taiwan
|
Liu, LT;Chiou, SS;Chen, PC;Chen, CH;Lin, PC;Tsai, CY;Chuang, WL;Hwang, SJ;Chong, IW;Tsai, JJ |
| 國家衛生研究院 |
2023-05-17 |
Identification and Analysis of SARS-CoV-2 Alpha Variants in the Largest Taiwan COVID-19 Outbreak in 2021[Erratum:Frontiers in Medicine. 2022 Apr 25;9:Article number 869818.]
|
Liu, LT;Tsai, JJ;Chang, K;Chen, CH;Lin, PC;Tsai, CY;Tsai, YY;Hsu, MC;Chuang, WL;Chang, JM;Hwang, SJ;Chong, IW |
| 國家衛生研究院 |
2023-03-23 |
The identification and phylogenetic analysis of SARS-CoV-2 delta variants in Taiwan
|
Liu, LT;Tsai, JJ;Chu, JJH;Chen, CH;Chen, LJ;Lin, PC;Tsai, CY;Hsu, MC;Chuang, WL;Hwang, SJ;Chong, IW |
| 國家衛生研究院 |
2022-04-25 |
Identification and analysis of SARS-CoV-2 alpha variants in the largest Taiwan COVID-19 outbreak in 2021
|
Liu, LT;Tsai, JJ;Chang, K;Chen, CH;Lin, PC;Tsai, CY;Tsai, YY;Hsu, MC;Chuang, WL;Chang, JM;Hwang, SJ;Chong, IW |
| 國家衛生研究院 |
2022-01-06 |
Isolation and identification of a rare spike gene double-deletion SARS-CoV-2 variant from the patient with high cycle threshold value
|
Liu, LT;Tsai, JJ;Chen, CH;Lin, PC;Tsai, CY;Tsai, YY;Hsu, MC;Chuang, WL;Chang, JM;Hwang, SJ;Chong, IW |
| 國家衛生研究院 |
2021-08-12 |
First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients
|
Huang, JF;Dai, CY;Huang, CF;Tsai, PC;Yeh, ML;Hsu, PY;Huang, SF;Bair, MJ;Hou, NJ;Huang, CI;Liang, PC;Lin, YH;Wang, CW;Hsieh, MY;Chen, SC;Lin, ZY;Yu, ML;Chuang, WL |
| 中山醫學大學 |
2021 |
EIGHT-YEAR ENTECAVIR THERAPY CONTINUOUSLY REDUCES LIVER ADVERSE EVENTS IN CHRONIC HEPATITIS B PATIENTS WITH CIRRHOSIS
|
Su, TH; Hu, TH; Chuang, WL; Su, WW; Lin, CC; Peng, CY; Wang, CC; Hsu, YC; Huang, YW; Tseng, KC; Lin, CL; Yang, SS; Suk, FM; Hsu, SJ; Chen, TM; Bair, MJ; Lin, CK; Hsieh, TY; Wang, HY; Tseng, TC; Kao, JH |
| 中山醫學大學 |
2021 |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, PN; Mo, LR; Chen, CT; Chen, CY; Huang, CF; Kuo, HT; Lo, CC; Tseng, KC; Huang, YH; Tai, CM; Peng, CY; Bair, MJ; Chen, CH; Yeh, ML; Lin, CL; Lin, CY; Lee, PL; Chong, LW; Hung, CH; Chang, T; Huang, JF; Yang, CC; Hu, JT; Lin, CW; Wang, CC; Su, WW; Hsieh, TY; Lin, CL; Tsai, WL; Lee, TH; Chen, GY; Wang, SJ; Chang, CC; Yang, SS; Wu, WC; Huang, CS; Chou, KH; Kao, CN; Tsai, PC; Liu, CH; Lee, MH; Cheng, CY; Tsai, MC; Liu, CJ; Dai, CY; Lin, HC; Kao, JH; Chuang, WL; Yu, ML |
| 中山醫學大學 |
2020 |
Executive summary of the DAROC clinical practice guidelines for diabetes care-2018 Diabetes Association of the Republic of China (Taiwan)
|
Chen, JF; Chen, HS; Chu, CH; Chuang, LM; Ho, LT; Hung, YJ; Kuo, CH; Li, HY; Lin, CH; Lin, KD; Lin, SY; Sheen, YJ; Sheu, WHH; Shin, SJ; Tsai, ST; Te Tu, S; Bai, CH; Chang, YC; Chang, TJ; Chang, CH; Chang, CJ; Chao, CC; Chen, CC; Chen, YL; Chong, K; Chuang, WL; Guo, LY; Hsieh, MC; Hsu, CC; Huang, LC; Huang, CN; Huang, YY; Hung, CS; Hung, WW; Hwu, CM; Jeng, JS; Jiang, YD; Juang, JMJ; Juang, JH; Kuo, CS; Kuo, JF; Kwok, CF; Lai, YC; Lee, MY; Lee, YJ; Lee, IT; Lee, CN; Lee, YT; Lee, TI; Lee, CH; Lin, LY; Lin, SD; Lin, KY; Lin, HJ; Lin, CH; Liu, CE; Lo, FS; Lu, CH; Lu, KC; Ma, WY; Ou, HY; Pei, D; Su, CC; Su, SL; Tan, ECH; Tien, KJ; Tsai, LK; Tseng, CH; Wang, JS; Weng, SF; Wu, WC; Yang, MC; Yang, YS; Yang, CH; Yang, WS; Yeh, JT; Yu, NC; Yu, TY |
| 臺大學術典藏 |
2018-09-10T06:55:38Z |
Downcoiler surface fault prediction for a hot strip steel mill
|
Hsu, Yl.;Yen, Jy.;Chen, Ch.;Chuang, Wl.;Jia-Yush Yen;Hsu, Y.-L.;Yen, J.-Y.;Chen, C.-H.;Chuang, W.-L.;Hsu, Yl.;Yen, Jy.;Chen, Ch.;Chuang, Wl.;Jia-Yush Yen; Chuang, W.-L.; Chen, C.-H.; Yen, J.-Y.; Hsu, Y.-L.; JIA-YUSH YEN |
| 國家衛生研究院 |
2017-01-04 |
The paradoxical effects of different Hepatitis C viral loads on host DNA damage and repair abilities
|
Wang, SC;Lai, KR;Li, CY;Chiang, CS;Yu, GY;Sakamoto, N;Tu, WY;Hsieh, MH;Huang, JF;Chuang, WL;Dai, CY;Yu, ML |
| 中國醫藥大學 |
2015-01 |
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B was associated with unexpected high rate of peripheral neuropathy
|
(Marcellin P)*;(Wursthorn K);(Wedemeyer H);(Chuang WL);(Lau G);(Avila C);彭成元(Cheng-Yuan Peng);(Gane E);(Lim SG);(Fainboim H);(Foster GR);(Safadi R);(Rizzetto M);(Manns M);(Bao W);(Naoumov N) |
| 高雄醫學大學 |
2015 |
Chronic hepatitis C infection is associated with insulin resistance and lipid profiles
|
戴嘉言;葉明倫;黃釧峰;侯正修;謝明彥;黃志富;林怡伶;林子堯;陳信成;王良彥;張文宇;董宏達; Dai, CY;Yeh, ML;Huang, CF;Hou, CH;Hsieh, MY;Huang, JF;Lin, IL;Lin, ZY;Chen, SC;Wang, LY;Chuang, WL;Yu, ML;Tung HD, . |
| 中國醫藥大學 |
2014-01 |
Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-na?ve Taiwanese patients with chronic hepatitis B
|
(Chien RN);彭成元(Cheng-Yuan Peng);(Kao JH);(Hu TH);(Lin CC);(Hu CT);(Chen CY);(Hsieh TY);(Lin HC);(Chuang WL)* |
| 高雄醫學大學 |
2014 |
Impact of chronic hepatitis B and hepatitis C on adverse hepatic fibrosis in hepatocellular carcinoma related to betel quid chewing.
|
鄭貞英;蔡孟峰;蔡蕙如;莊麗月;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言;蔡榮發; Jeng, JE;Tsai, MF;Tsai, HR;Chuang, LY;Lin, ZY;Hsieh, MY;Chen, SC;Chuang, WL;Wang, LY;Yu, ML;Dai, CY;Tsai, JF |
| 高雄醫學大學 |
2014 |
Abbott RealTime HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analogues Therapy.
|
葉明倫;黃釧峰;黃駿逸;劉淑芬;楊華齡;謝明彥;黃志富;戴嘉言;莊萬龍;余明隆; Yeh, ML;Huang, CF;Huang, CI;Liu, SF;Yang, HL;Hsieh, MY;Huang, JF;Dai, CY;Chuang, WL;Yu, ML |
| 高雄醫學大學 |
2014 |
inosine triphosphate pyrophosphatase 基因變異與慢性C型肝炎2/3基因型治療復發危險
|
戴嘉言;莊萬龍;余明隆; Dai, CY;Chuang, WL;Yu, ML |
| 高雄醫學大學 |
2014 |
A 24-Week Pegylated Interferon Alpha-2b Versus a 12-Week Pegylated Interferon Alpha-2b Alone or With Ribavirin for Patients With Acute Hepatitis C
|
戴嘉言;莊萬龍;余明隆; Dai, CY;Chuang, WL;ML*, Yu |
| 國家衛生研究院 |
2013-12 |
ENSA expression correlates with attenuated tumor propagation in liver cancer
|
Chen, YL;Kuo, MH;Lin, PY;Chuang, WL;Hsu, CC;Chu, PY;Lee, CH;Huang, THM;Leu, YW;Hsiao, SH |
| 中國醫藥大學 |
2013-03 |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced HBeAg seroconversion
|
(Yang HC);(Chen CL);(Shen YC);彭成元(Cheng-Yuan Peng);(Liu CJ);(Tseng TC);(Su TH);(Chuang WL);(Yu ML);(Dai CY);(Liu CH);(Chen PJ);(Chen DS);(Kao JH)* |
| 高雄醫學大學 |
2013 |
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin.
|
GR*, Foster;Zeuzem, S;Pianko, S;Sarin, SK;Piratvisuth, T;Shah, S;Andreone, P;Sood, A;莊萬龍;Lee, CM;George, J;Gould, M;Flisiak, R;Jacobson, IM;Komolmit, P;Thongsawat, S;Tanwandee, T;Rasenack, J;Sola, R;Messina, I;Yin, Y;Cammarata, S;Feutren, G;Brown, KK. ; Foster, GR;Zeuzem, S;Pianko, S;Sarin, SK;Piratvisuth, T;Shah, S;Andreone, P;Sood, A;Chuang, WL;Lee, CM;George, J;Gould, M;Flisiak, R;Jacobson, IM;Komolmit, P;Thongsawat, S;Tanwandee, T;Rasenack, J;Sola, R;Messina, I;Yin, Y;Cammarata, S;Feutren, G;Brown, KK. |
| 高雄醫學大學 |
2012 |
Waist circumference; body mass index; serum uric acid; blood sugar; and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population.
|
謝孟軒;林文一;潛詡涵;簡麗合;黃兆寬;楊正福;張寧家;黃釧峰;王肈齡;莊萬龍;余明隆;戴嘉言;何啟功 ; Hsieh, MH;Lin, WY;Chien, HH;Chien, LH;Huang, CK;Yang, JF;Chang, NC;Huang, CF;Wang, CL;Chuang, WL;Yu, ML;Dai, CY;Ho, CK |
| 高雄醫學大學 |
2011 |
Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection.
|
黃志富;黃釧峰;余明隆;戴嘉言;黃駿逸;葉明倫;謝明裕;楊正福;謝明彥;林子堯;陳信成;莊萬龍 ; Huang JF;Huang CF;Yu ML;Dai CY;Huang CI;Yeh ML;Hsieh MH;Yang JF;Hsieh MY;Lin ZY;Chen SC;Chuang WL |
| 高雄醫學大學 |
2011 |
老年人C型肝炎
|
黃釧鋒;莊萬龍;余明隆 ; Huang CF;Chuang WL;Yu ML. |
| 高雄醫學大學 |
2011 |
Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.
|
莊萬龍; Patel K;Thompson AJ;Chuang WL;Lee CM;Peng CY;Shanmuganathan G;Thongsawat S;Tanwandee T;Mahachai V;Pramoolsinsap C;Cho M;Han KH;Shah SR;Foster GR;Clark PJ;Pulkstenis E;Subramanian GM;McHutchison JG. |
| 高雄醫學大學 |
2011 |
Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.
|
楊正福;林雅雲;謝孟軒;蔡秋鴻;劉淑芬;余明隆;戴嘉言;黃志富;林文一;林子堯;陳信成;莊萬龍 ; Yang JF;Lin YY;Hsieh MH;Tsai CH;Liu SF;Yu ML;Dai CY;Huang JF;Lin WY;Lin ZY;Chen SC;Chuang WL. |
| 高雄醫學大學 |
2010 |
C型肝炎病毒基因型第2/3型病毒病患以長效干擾素/雷巴威林縮短療程合併治療:雷巴威林起始劑量之重要角色
|
戴嘉言;黃釧峰;黃志富;莊萬龍;余明隆 ; Dai CY;Huang CF;Huang JF;Chuang WL;Yu ML |
| 高雄醫學大學 |
2010 |
Insulin resistance predicts rapid virological response in non-diabetic; non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: Some issues.
|
吳冠達;楊正福;莊萬龍;余明隆 ; Wu KT;Yang JF;Chuang WL;Yu ML |
| 高雄醫學大學 |
2009 |
Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms; substance use habits; and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma.
|
鄭貞英;蔡蕙如;莊麗月;蔡榮發;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言;張建國 ; Jeng JE;Tsai HR;Chuang LY;Tsai JF;Lin ZY;Hsieh MY;Chen SC;Chuang WL;Wang LY;Yu ML;Dai CY;Chang JG. |
| 高雄醫學大學 |
2009 |
ribavirin早期劑量與C型肝炎病毒基因型第一型病毒合併治療反應之角色
|
戴嘉言;黃釧峰;莊萬龍;黃志富;余明隆 ; Dai CY;Huang CF;Chuang WL;Huang JF;Yu ML |
| 高雄醫學大學 |
2009 |
雷巴威林起始劑量與C型肝炎病毒基因型第1b亞型病毒以長效干擾素/雷巴威林合併治療反應之重要角色
|
戴嘉言;黃釧峰;莊萬龍;黃志富;余明隆 ; Dai CY;Huang CF;Chuang WL;Huang JF;Yu ML |
| 高雄醫學大學 |
2009 |
Treatment of chronic hepatitis C in Asia: when East meets West.
|
余明隆;莊萬龍 ; Yu ML;Chuang WL |
| 高雄醫學大學 |
2009 |
Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.
|
張美惠;陳定信;莊萬龍; Chang MH;You SL;Chen CJ;Liu CJ;Lee CM;Lin SM;Chu HC;Wu TC;Yang SS;Kuo HS;Chen DS;Chuang WL;etal. |
| 高雄醫學大學 |
2009 |
C型肝炎病毒血症型與血脂值:流行病學研究線索
|
戴嘉言;莊萬龍;何啟功; , 余明隆; Dai, CY;Chuang, WL;Ho, CK; , Yu ML |
| 高雄醫學大學 |
2009 |
Independent;additive interactive effects among tumor necrosis factor-alpha polymorphisms;substance use habits;and chronic hepatitis B;hepatitis C virus infection on risk for hepatocellular carcinoma.
|
鄭貞英;蔡蕙如;莊麗月;蔡榮發;林子堯;謝明裕;陳信成;莊萬龍;王良彥;余明隆;戴嘉言;張建國 ; Jeng, JE;Tsai, HR;Chuang, LY;Tsai, JF;Lin, ZY;Hsieh, MY;Chen, SC;Chuang, WL;Wang, LY;Yu, ML;Dai, CY;Chang JG, . |
| 臺北醫學大學 |
2008 |
伸展運動對改善護理人員下背痛之成效探討
|
陳品玲; Chen MM; Lee SF; Chuang WL; Chen PL |
| 高雄醫學大學 |
2008 |
一種實時間反轉錄多聚酶鏈反應試劑應用於基因型第一與第二型C型肝炎病毒定量測定之表現特徵
|
黃志富;戴嘉言;林雅雲;余明隆;劉淑芬;林怡伶;謝明彥;李立柏;林子堯;陳信成;謝明裕;張文宇;莊萬龍 ; Huang JF;Dai CY;Lin YY;Yu ML;Liu SF;Lin IL;Hsieh MY;Lee LP;Lin ZY;Chen SC;Hsieh MY;Chang WY;Chuang WL |
| 高雄醫學大學 |
2008 |
Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues.
|
余明隆;戴嘉言;黃志富;謝明彥;莊萬龍 ; Yu ML;Dai CY;Huang JF;Hsieh MY;Chuang WL. |
| 高雄醫學大學 |
2008 |
基因型第二型慢性C型肝炎病毒建議以較短療程合併治療快速病毒反應之可能決定因素
|
戴嘉言;莊萬龍;黃志富;謝明彥;余明隆 ; Dai CY;Chuang WL;Huang JF;Hsieh MY;Yu ML |
| 高雄醫學大學 |
2008 |
C型肝炎病毒血症與較低之血清三酸甘油脂及膽固醇值相關:一社區研究
|
戴嘉言;莊萬龍;何啟功;謝明彥;黃志富;李立柏;侯乃仁;林子堯;陳信成;謝明裕;王良彥;蔡榮發;張文宇;余明隆; Dai, CY;Chuang, WL;Ho, CK;Hsieh, MY;Huang, JF;Lee, LP;Hou, NJ;Lin, ZY;Chen, SC;Hsieh, MY;Wang, LY;Tsai, JF;Chang, WY;Yu, ML |
| 國立臺灣大學 |
2008 |
Downcoiler surface fault prediction for a hot strip steel mill
|
Chuang, WL.; Chen, CH.; Yen, JY.; Hsu, YL. |
| 國立臺灣大學 |
2007-09 |
Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan.
|
Sullivan, SD; Veenstra, DL; Chen, PJ; Chang, TT; Chuang, WL; Tsai, C; Patel, K. |
显示项目 1-50 / 84 (共2页)
1 2 > >>
每页显示[10|25|50]项目
|
